Published in Hepatitis Weekly, February 26th, 2007
Great strides have been made in understanding the complex pathogen-host interactions that lead to these serious sequelae. While major therapeutic advances have occurred in the past 15 years in treating chronic viral hepatitis, major unmet medical needs remain in terms of tolerability and efficacy of existing therapies.
Considering this need, ALM's Strategic Research Institute will bring together global thought leaders from academic and industrial research for two days of focused...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly